HELIX THERAPEUTICS, LLC

Basic Information

HELIX THERAPEUTICS, LLC
25 Science Park
New Haven, CT, 06511

Company Profile

n/a

Additional Details

Field Value
DUNS: 788852437
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Beta-Globin Gene Correction Using Peptide Nucleic Acids for the Treatment of Sick

    Amount: $228,490.00

    DESCRIPTION (provided by applicant): This is a proposal to test the feasibility of using triplex-forming oligonucleotides to correct the sickle cell disease (SCD) mutation in human CD34+ cells. SCD is ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. Targeted CCR5 Gene Inactivation Using Peptide Nucleic Acids

    Amount: $99,999.00

    DESCRIPTION (provided by applicant): The proposed work is to develop a therapeutic gene targeting agent for the treatment of HIV disease. Our approach is to use triplex-forming oligonucleotides (TFOs) ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government